[Immunotherapy in the complex treatment of patients with atopic dermatitis with sensitization to house dust mites].
Ninety-nine patients aged 16-52 years with disseminated atopic dermatitis at the remission were examined and treated. The patients were divided into 3 groups according to the method of therapy. Group 1 (28 patients aged 17-52 years, found to be sensitive to Dermatophagoides pteronyssinus and D. farinae) received, in addition to standard treatment, immunotherapy (oral hyposensitization with mite allergens) in combination with ointment containing retinopalmitate and methyluracil. Group 2 (39 patients aged 17-40 years) received standard treatment combined with the administration of placebo. Group 3 (32 patients aged 16-27 years) received only standard therapy. Groups 2 and 3 were used for comparison. The results of treatment were evaluated according to changes in the immune status of the patients and a complex of clinical characteristics. Essential improvement in clinical characteristics and the normalization of immunological parameters were registered in group 1, which proved that immunotherapy was effective and safe.
Mechnikov Research Institute for Vaccines and Sera, Moscow, Russia.
S Iu
SIu
Petrova
V M
VM
Berzhets
V I
VI
Al'banova
T F
TF
Bystritskaia
N S
NS
Petrova
D000293:Adolescent; D000328:Adult; D000818:Animals; D003876:Dermatitis, Atopic / Q000276:immunology / Q000628:therapy*; D005260:Female; D006801:Humans; D007167:Immunotherapy; D008297:Male; D008925:Mites / Q000276:immunology*; D010919:Placebos
D010919:Placebos